Medical use of cannabis products: Lessons to be learned from Israel and Canada

Der Schmerz
J AblinM-A Fitzcharles

Abstract

The German government intends to reduce the barriers for the medical use of cannabis products. A discussion on the indications and contraindications of the medical use of cannabis and on the changes of the regulatory framework has already begun in Germany. It is useful to draw from the experiences of other countries with a more liberal medical use of cannabis. The Israeli and Canadian experience is outlined by physicians who have been charged with expertise on the medical use of cannabis by their jurisdiction. In Israel, only the plant-based cannabinoid nabiximol (mixture of tetrahydrocannabinol/cannabidiol) can be prescribed for spasticity/chronic pain in multiple sclerosis and for cancer pain. The costs of nabiximole are reimbursed by some, but not by all health maintenance organizations. The medical use of marijuana is permitted; however, it is strictly regulated by the government. Selected companies are allowed to produce marijuana for medical use, and only certain physicians are licensed to prescribe marijuana as a therapeutic drug for specific indications such as chronic neuropathic, and cancer pain, inflammatory bowel diseases, or posttraumatic stress disorder if conventional treatments have failed. The costs of marijuan...Continue Reading

References

Feb 21, 2002·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·H Kalant
Jul 20, 1965·Journal of the American Chemical Society·R MECHOULAM, Y GAONI
Aug 3, 2010·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Yvonne M Buys, Paul E Rafuse
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Roger G Pertwee
Mar 13, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·John Fletcher
Sep 3, 2014·The Journal of Rheumatology·Mary-Ann Fitzcharles, Shahin Jamal
Jun 24, 2015·JAMA : the Journal of the American Medical Association·Deepak Cyril D'Souza, Mohini Ranganathan
Dec 19, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN ACMG Board of Directors

❮ Previous
Next ❯

Citations

Jan 27, 2016·Der Schmerz·L Radbruch, M Schäfer
Mar 23, 2017·Pain·Brian J PiperRebecca M DeKeuster
Mar 8, 2018·The Cochrane Database of Systematic Reviews·Martin MückeWinfried Häuser
Feb 5, 2019·Journal of Palliative Medicine·Michael J Tatterton, Charlotte Walker
May 28, 2019·Journal of Neural Transmission·Carsten BuhmannFlorin Gandor
Apr 26, 2020·Current Opinion in Supportive and Palliative Care·Howard MengHance Clarke
May 31, 2020·Regional Anesthesia and Pain Medicine·Hance ClarkeLakshmi P Kotra
Nov 30, 2018·Drugs & Aging·Amir MinerbiMary-Ann Fitzcharles
Feb 23, 2019·Clinical Orthopaedics and Related Research·Jason M JenningsDouglas A Dennis
Dec 3, 2017·The International Journal of Eating Disorders·Holmer GraapGeorgios Paslakis
Sep 13, 2019·Expert Review of Clinical Immunology·Piercarlo Sarzi-PuttiniWinfred Hauser
Feb 26, 2021·Nature Reviews. Disease Primers·Jason P ConnorWayne D Hall
Aug 3, 2021·Journal of Addictive Diseases·Ory ZloczowerEinat Peles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Related Papers

The Open Neurology Journal
Igor GrantBarth Wilsey
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Henry J McQuay
© 2022 Meta ULC. All rights reserved